Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12404508
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
granted -
US 12403202
Dosage of claudin-6 conjugates for cancer treatment
granted -
US 12403134
Method for improving or enhancing cognition
granted -
US 12404505
Delivery of a gene-editing system with a single retroviral particle and methods of generation and use
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12404315
Protease-activating CD45-gate CAR
granted -
US 12404313
GDNF fusion polypeptides and methods of use thereof
granted -
US 12404347
Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof
granted -
US 12404335
Compositions and methods for treatment of thyroid eye disease
granted -
US 12402611
Genetically modified mice and engraftment
granted -
US 12404328
Multi-specific binding proteins and methods of use thereof
granted -
US 12404337
Compositions, doses, and methods for treatment of thyroid eye disease
granted -
US 12404318
Combination HBV therapy
granted -
US 12404533
Bioconjugate vaccines' synthesis in prokaryotic cell lysates
granted -
US 12403192
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 12404243
Inhibitors of the Wnt/beta-catenin pathway
granted -
US 12404275
Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403183
Factor VIII polypeptide formulations
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12403203
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12403087
Topical antiviral compositions, delivery systems, and methods of using the same
granted -
US 12403093
Methods for production of MSC-derived exosomes
granted -
US 12403141
Deuterated MK2 pathway inhibitors and methods of using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.